(Q35814456)

10 August 2017

1 reference

title

The therapeutic potential of CRF1 antagonists for anxiety (English)

1 reference

10 August 2017

2

George F Koob

1 reference

10 August 2017

Eric P Zorrilla

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Expert Opinion on Investigational Drugs

10 August 2017

published in

1 reference

10 August 2017

volume

13

1 reference

10 August 2017

issue

7

1 reference

10 August 2017

page(s)

799-828

1 reference

Economic costs of anxiety disorders.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The relationship between anxiety and substance use disorders among individuals with severe affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Generalized anxiety disorder: prevalence, burden, and cost to society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Excess mortality among 3302 patients with 'pure' anxiety neurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Quality of life in individuals with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The quality of care for depressive and anxiety disorders in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Clinical practice. Obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Nibbling at CRF receptor control of feeding and gastrocolonic motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Molecular biology of the CRH receptors-- in the mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Isolation of the human plasma corticotrophin-releasing factor-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Ligand requirements of the human corticotropin-releasing factor-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The corticotrophin-releasing factor-binding protein: an act of several parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Central administration of corticotropin-releasing factor modulates oxytocin secretion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Central Nervous System Regulation of Adrenocorticotropin Secretion: Role of Somatostatins*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Lessons from CRH knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Increase of urocortin-like immunoreactivity in the rat supraoptic nucleus after dehydration but not food deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The CRF peptide family and their receptors: yet more partners discovered

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotrophin-releasing factor receptors: from molecular biology to drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Distribution of corticotropin-releasing factor-like immunoreactivity in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The role of CRH in behavioral responses to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

EEG stability following corticotropin releasing factor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

CRF-induced seizures and behavior: interaction with amygdala kindling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Neurophysiological effects of intracerebroventricular administration of urocortin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin releasing factor produces behavioural activation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor administered intraventricularly to rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Intracerebroventricular porcine corticotropin-releasing hormone and cortisol effects on pig immune measures and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Behaviour of pigs given corticotrophin-releasing hormone in combination with flumazenil or diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Behavioral and hormonal effects of centrally injected "anxiogenic" neuropeptides in growing pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

CRF-induced excessive grooming behavior in rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Interaction of corticotropin-releasing factor and glucagon-like peptide-1 on behaviors in chicks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Central administration of corticotropin-releasing hormone stimulates locomotor activity in juvenile chinook salmon (Oncorhynchus tshawytscha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor (CRF) antagonist suppresses stress-induced locomotor activity in an amphibian

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of corticotropin-releasing factor (CRF) and opiates on amphibian locomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Urocortin, a novel neuropeptide with anxiogenic-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The behavioural effects of corticotropin-releasing factor-related peptides in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Intracerebroventricularly administered corticotropin-releasing factor inhibits food intake and produces anxiety-like behaviour at very low doses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Differential behavioral and endocrinological effects of corticotropin-releasing hormone (CRH) in the Syracuse high- and low-avoidance rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of corticotropin releasing factor and sauvagine on social behavior of isolated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Posttraumatic stress symptoms in victims of childhood incest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Fear-potentiated startle in adolescent offspring of parents with anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Behavioral effects Of 8-OH-DPAT in chronically stressed male and female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Locus coeruleus involvement in the effects of immobilization stress on the p13 midlatency auditory evoked potential in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Prepulse inhibition deficits in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Sensory gating in chronic posttraumatic stress disorder: reduced auditory P50 suppression in combat veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Combat veterans with posttraumatic stress disorder exhibit decreased habituation of the P1 midlatency auditory evoked potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Differential behavioral actions of corticotropin-releasing factor (CRF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor enhances sodium and water intake/excretion in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Behavioral and physiologic effects of CRH administered to infant primates undergoing maternal separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Interactions of corticotropin-releasing factor with antidepressant and anxiolytic drugs: behavioral studies with pigeons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Interaction between the cholinergic system and CRH in the modulation of spatial discrimination learning in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Regional hemodynamic responses to central administration of corticotropin-releasing factor (CRF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Central nervous system actions of corticotropin-releasing factor on cardiovascular function in the absence of locomotor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Comparison of hCRF and oCRF effects on cardiovascular responses after central, peripheral, and in vitro application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Behavioral and cardiac responses after intracerebroventricular corticotropin-releasing hormone (CRH) administration: role of adrenal cortical hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Central actions of CRF on thermogenesis are mediated by pro-opiomelanocortin products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Long-term effects on feeding and body weight after stimulation of forebrain or hindbrain CRH receptors with urocortin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Prevalence of irritable bowel syndrome among university students: the roles of worry, neuroticism, anxiety sensitivity and visceral anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Comorbidity of irritable bowel syndrome in psychiatric patients: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The role of corticotropin-releasing factor in depression and anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Cerebrospinal fluid neuropeptides in mood disorder and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Brain corticotropin-releasing hormone increases arousal in stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Psychological stress increases arousal through brain corticotropin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Restraint changes pentobarbital-induced sleeping time in rats: evidence that arousal is modulated by brain corticotropin-releasing hormone and opioid in stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Hyperactivity of central noradrenergic and CRF systems is involved in social isolation-induced decrease in pentobarbital sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Behavioral effects of central administration of the novel CRF antagonist astressin in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor receptor blockade enhances conditioned aversive properties of cocaine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The neurobiology and control of anxious states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Animal model for investigating the anxiogenic effects of self-administered cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Role of CRF(1) and CRF(2) receptors in fear and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Therapeutic potential of CRF receptor antagonists: a gut-brain perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Bi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Arylamidrazones as novel corticotropin releasing factor receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Synthesis and biological activity of oxo-7H-benzo[e]perimidine-4-carboxylic acid derivatives as potent, nonpeptide corticotropin releasing factor (CRF) receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Synthesis, molecular modeling and biological activity of methyl and thiomethyl substituted pyrimidines as corticotropin releasing hormone type 1 antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Sigma receptors: from discovery to highlights of their implications in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Neuropeptide Y receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Synthesis of 3-phenylpyrazolo[4,3-b]pyridines via a convenient synthesis of 4-amino-3-arylpyrazoles and SAR of corticotropin-releasing factor receptor type-1 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Synthesis of 1-methyl-3-phenylpyrazolo[4,3-b]pyridines via a methylation of 4-phthalimino-3-phenylpyrazoles and optimization toward highly potent corticotropin-releasing factor type-1 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Brain pharmacokinetics of a nonpeptidic corticotropin-releasing factor receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Receptor occupancy of nonpeptide corticotropin-releasing factor 1 antagonist DMP696: correlation with drug exposure and anxiolytic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Is there a difference between leads and drugs? A historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Lercanidipine : a review of its efficacy in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CR

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The CRH1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The anxiolytic CRF(1) antagonist DMP696 fails to function as a discriminative stimulus and does not substitute for chlordiazepoxide in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Survival of a 75% burn in a patient with longstanding Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Pyrazolo-[1,5-a]-1,3,5-triazine corticotropin-releasing factor (CRF) receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Neuroprotective effects of the CRF1 antagonist R121920 after permanent focal ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of a non-peptide CRF antagonist (DMP696) on the behavioral and endocrine sequelae of maternal separation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Involvement of corticotropin-releasing factor in the retrieval process of fear-conditioned ultrasonic vocalization in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Peripheral administration of CRF and urocortin: effects on food intake and the HPA axis in the marsupial Sminthopsis crassicaudata

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

Relationships between feeding and locomotion behaviors after central administration of CRF in chicks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.7.799

10.1517/13543784.13.7.799

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference